BDSX - CIK 0001439725
The table below shows BIODESIX INC's balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $18.99M | $26.25M | $26.28M | $43.09M | $32.71M | $62.13M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $9.04M | $8.60M | $7.68M | $5.07M | $3.66M | $15.30M |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $32.52M |
| $39.48M |
| $39.68M |
| $53.33M |
| $43.61M |
| $86.14M |
| Property, plant & equipment | $24.82M | $27.83M | $27.87M | $5.85M | $4.18M | $3.18M |
| Goodwill | $15.03M | $15.03M | $15.03M | $15.03M | $15.03M | $15.03M |
| Total assets | $87.48M | $97.24M | $99.10M | $92.91M | $76.10M | $121.07M |
| Accounts payable | $3.08M | $2.19M | $2.93M | $1.69M | $1.66M | $8.96M |
| Total current liabilities | $17.44M | $14.32M | $33.42M | $22.84M | $28.96M | $32.13M |
| Long-term debt | $50.01M | $40.03M | $40.08M | $30.13M | $10.07M | $28.08M |
| Total liabilities | $89.94M | $76.37M | $94.52M | $72.30M | $56.37M | $79.90M |
| Retained earnings | -$497.76M | -$462.50M | -$419.57M | -$367.42M | -$301.97M | -$258.81M |
| Total equity | -$2.46M | $20.88M | $4.58M | $20.61M | $19.73M | $41.17M |